当前位置: 首页 > 期刊 > 《中国现代医生》 > 2022年第17期
编号:668153
老年慢性阻塞性肺疾病合并肺结核患者临床治疗的效果观察与分析
http://www.100md.com 2022年7月18日 中国现代医生 2022年第17期
     黄秋琴 雷鸣 夏莹

    [摘要] 目的 探究老年慢性阻塞性肺疾病(慢阻肺)合并肺結核患者抗结核治疗的临床效果及应用价值。方法? 遴选2019年3月~2021年3月长沙市中心医院收治的老年慢阻肺合并肺结核患者40例,参考“系统抽样法”,将研究对象分为对照组和观察组,每组各20例,对照组实施常规治疗,观察组常规治疗+抗结核治疗。评价指标:临床总疗效、肺功能指标、肺部阴影、空洞改善情况及痰菌转阴率。结果? 观察组患者治疗总疗效95.00%明显高于对照组的70.00%(P<0.05)。观察组双肺阴影消失率(90.00%)、胸片空洞改善率(85.00%)、痰菌转阴率(80.00%)明显高于对照组(60.0%、55.00%、50.00%)(均P<0.05)。经治疗后观察组较对照组FEV1、FVC、IC水平均更高,RV、TLC水平更低(均P<0.05)。结论? 针对老年慢阻肺合并肺结核患者实施抗结核治疗,临床疗效确切,有利于患者临床症状、体征改善,促进肺功能恢复,实现理想的治疗效果。

    [关键词] 老年慢性阻塞性肺疾病;肺结核;抗结核治疗;临床疗效;痰菌转阴

    [中图分类号] R563.9;R521? ? ? ? ? [文献标识码] B? ? ? ? ? [文章编号] 1673-9701(2022)17-0102-04

    Observation and analysis of clinical efficacy of elderly patients with chronic obstructive pulmonary disease complicated with pulmonary tuberculosis

    HUANG Qiuqin? ?LEI Ming? ?XIA Ying

    Ward Ⅲ of Pulmonology Department, Changsha Central Hospital, Changsha 410004, China

    [Abstract] Objective To explore the clinical efficacy and application value of anti-tuberculosis therapy in elderly patients with chronic obstructive pulmonary disease (COPD) complicated with pulmonary tuberculosis. Methods A total of 40 elderly patients with COPD combined with pulmonary tuberculosis who were admitted to the Changsha Central Hospital from March 2019 to March 2021 were selected as the research subjects and divided into the control group and the observation group according to the “systematic sampling method” ......

您现在查看是摘要页,全文长 13280 字符